The Infectious Disease Specialist as the Catalyst for Informed Anti-infective Decision Making in the Hospital Setting: Focus on CABP and ABSSSI
Release Date: January 5, 2012
Last Reviewed: December 6, 2011
Expiration Date: January 5, 2014
Time to complete activity: 1.50 hours
The content of this activity was originally presented as an evening symposium held following the Official Programming of the 40th Annual Meeting of the IDSA on October 21, 2011.
SPEAKERS
Thomas M. File, Jr, MD, MSc, MACP, FIDSA, FCCP (Chair)Professor, Internal Medicine; Master TeacherChair, Infectious Disease SectionNortheast Ohio Medical UniversityRootstown, OHChair, Infectious Disease DivisionSumma Health SystemAkron, OH
Ellie J.C. Goldstein, MD, FIDSA
Clinical Professor of Medicine
David Geffen School of Medicine at UCLA
Director, R.M. Alden Research Laboratory
Santa Monica, CA
Michael J. Rybak, PharmD, MPH, FCCP, FIDSAProfessor of Pharmacy and MedicineDirector, Anti-Infective Research LaboratoryDepartment of Pharmacy PracticeEugene Applebaum College of PharmacyWayne State UniversityDetroit, MI
TARGET AUDIENCE
This activity has been designed to meet the educational needs of physicians specializing in the area of infectious disease and other healthcare professionals who manage patients with CABP and ABSSSI.
STATEMENT OF NEED
Community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI) are two of the most common and serious infections requiring hospital admission. Management of these infections is often complicated by the fact that hospitalized patients are often elderly, and have multiple comorbidities.
To meet quality standards that ensure optimal patient outcomes, to maximize reimbursement, and to reduce future antibiotic resistance, clinicians must select the most effective empiric antibiotic regimen–which includes finding a role for newer agents that may offer certain advantages based on their profile. Infectious disease specialists should take a leadership role within their institutions to ensure optimal management of CABP and ABSSSI by serving as consultants and educators to other healthcare professionals, and by developing and implementing clinical practice standards and guidelines.
EDUCATIONAL OBJECTIVES
Upon proper completion of this activity, participants should be able to:
- Apply current clinical evidence to the appropriate management of patients with ABSSSI.
- Apply current clinical evidence to the appropriate management of patients with CABP.
- Demonstrate leadership to ensure integration of established and newer antimicrobial agents into the clinical care of patients with ABSSSI and CABP based on the principles of antimicrobial stewardship.
DISCLOSURES
In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
Thomas M. File, Jr, MD, MSc, MACP, FIDSA, FCCP
Grant/Research Support: Boehringer Ingelheim GmbH; Gilead Sciences, Inc.; The Medicines Company; Pfizer Inc.; Tibotec Pharmaceuticals
Retained Consultant: Astellas Pharma; Bayer AG; Daiichi Sankyo Co., Ltd; Forest Laboratories, Inc.; Merck & Co., Inc; Nabriva Therapeutics AG, Tetraphase Pharmaceuticals
Ellie J.C. Goldstein, MD, FIDSA
Grant/Research Support: Astellas Pharma, AvidBiotics Corp.; Cerexa, Inc.; Clinical Microbiology Institute Inc.; Cubist Pharmaceuticals; Genzyme Corporation; GLSynthesis Inc.; Immunome Inc.; Impex Pharmaceuticals; Merck & Co., Inc; Nanopacific Holdings, Inc.; Novartis AG; Novexel; Optimer Pharmaceuticals, Inc.; Pfizer Inc.; Romark Laboratories, LC; Schering-Plough; Theravance, Inc.; Toltec Pharmaceuticals, LLC.; ViroXis Corporation; Warner Chilcott
Retained Consultant: Bayer AG; Bio-K Plus International Inc.; Kindred Healthcare, Inc.; Merck & Co., Inc; Optimer Pharmaceuticals, Inc.
Speakers Bureau: Bayer AG; Forest Laboratories, Inc.; Merck & Co., Inc; Sanofi-Pasteur
Michael J. Rybak, PharmD, MPH, FCCP, FIDSA
Grant/Research Support: Astellas Pharma; Cubist Pharmaceuticals; Forest Laboratories, Inc.
Retained Consultant: Cubist Pharmaceuticals; Forest Laboratories, Inc.; Pfizer Inc.
Speakers Bureau: Cubist Pharmaceuticals; Forest Laboratories, Inc.
Paradigm Medical Communications, LLC staff members have no financial conflicts to disclose.
Independent peer reviewer has no financial conflicts to disclose.
ACCREDITATION AND CREDIT DESIGNATION
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by an educational grant from Forest Laboratories, Inc.
This educational activity is sponsored by Paradigm Medical Communications, LLC, Orangeburg, NY.
INSTRUCTION FOR PARTICIPATION
To receive a CME statement of credit, participants should:
- Follow instructions to register or log in with your professional information and complete the pre-test.
- View the online activity in its entirety.
- Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the activity.
- A certificate of credit will be available for download/printing immediately following your successful completion of the posttest and evaluation.
There is no fee required for participation in this activity.
HARDWARE/SOFTWARE REQUIREMENTS
- Adobe Flash Player 8 or higher (Update or download: http://www.adobe.com/support/flashplayer/downloads.html)
- High speed internet connection, wired is recommended
- Speakers or headphones
- Internet browser
- For Windows: Internet Explorer, Firefox, Safari, Google Chrome
- For Mac: Safari, Firefox, Google Chrome
We recommended that you test your system prior to viewing the program. Please click on the link for our simple system test and follow the onscreen instructions. If you encounter any issues running the test, or do not receive green check marks at the end, please contact Technical Support.
Technical Support: If you have any technical problems or questions, please call 877-843-9272.
RESOLUTION OF CONFLICT OF INTEREST
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each continuing medical education activity to help ensure content objectivity, independence, fair balance, and that the content is aligned with the interest of the public. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
©2011 Paradigm Medical Communications, LLC, except where noted. This web presentation may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.
DISCLAIMER
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
TERMS OF USE AND PRIVACY POLICY
Disclaimer
The materials provided on this website are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented on this website are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content of any pages referenced in this website.
Privacy policy
Paradigm Medical Communications, LLC is committed to protecting the privacy of those who choose to participate in the activities (herein referred to as "website") located at www.paradigmmc.com. This information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information
To earn CME credits using the website, the submission of certain personally identifiable information is necessary. The required items include: first name, last name, degree, and e-mail address. These items are necessary to award and track the credits and participants may earn after completing the program. Participants are required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and assists the staff of Paradigm Medical Communications, LLC in continuously improving the learning experience.
Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participant's credits.
CONTACT US
If you have any questions or comments regarding this policy, please send e-mail to contactus@paradigmmc.com
For additional CME offerings, please visit www.paradigmmc.com.